Compass Therapeutics, Inc.
CMPX
$2.25
-$0.01-0.44%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 7.40M | 6.91M | 4.32M | 2.99M | 4.65M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 26.98M | 20.30M | 17.99M | 15.82M | 21.07M |
| Operating Income | -26.98M | -20.30M | -17.99M | -15.82M | -21.07M |
| Income Before Tax | -25.15M | -18.32M | -15.72M | -14.26M | -19.88M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -25.15M | -18.32M | -15.72M | -14.26M | -19.88M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -25.15M | -18.32M | -15.72M | -14.26M | -19.88M |
| EBIT | -26.98M | -20.30M | -17.99M | -15.82M | -21.07M |
| EBITDA | -26.96M | -20.28M | -17.97M | -15.80M | -20.97M |
| EPS Basic | -0.13 | -0.10 | -0.09 | -0.08 | -0.14 |
| Normalized Basic EPS | -0.08 | -0.06 | -0.05 | -0.05 | -0.09 |
| EPS Diluted | -0.13 | -0.10 | -0.09 | -0.08 | -0.14 |
| Normalized Diluted EPS | -0.08 | -0.06 | -0.05 | -0.05 | -0.09 |
| Average Basic Shares Outstanding | 186.80M | 186.40M | 184.84M | 168.78M | 138.28M |
| Average Diluted Shares Outstanding | 186.80M | 186.40M | 184.84M | 168.78M | 138.28M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |